Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1619, 2008-01, pp. : 6-6
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Validity of Cost and Utility Results?
PharmacoEconomics, Vol. 30, Iss. 10, 2012-10 ,pp. :
Access to resources
Recommend
Ramipril, rosiglitazone for atherosclerosis: STARR results?
Inpharma, Vol. 1, Iss. 1585, 2007-01 ,pp. :
Prescribing HRT to change following trial results?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 384, 2002-01 ,pp. :
Newer drugs for rheumatoid arthritis worth their cost?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 338, 2001-01 ,pp. :
Rituximab therapy effective for rheumatoid arthritis?
Inpharma, Vol. 1, Iss. 1443, 2004-01 ,pp. :